ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus

Abbott Laboratories ABT is slated to report second-quarter 2025 results on July 17, before the opening bell.The company delivered adjusted earnings per share (EPS) of $1.09 in the last quarter, which surpassed the Zacks Consensus Estimate by 1.9%. Its earnings exceeded the Zacks Consensus Estimate in each of the trailing...